Filing Details
- Accession Number:
- 0001179110-12-014377
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-09-21 18:59:47
- Reporting Period:
- 2012-09-19
- Filing Date:
- 2012-09-21
- Accepted Time:
- 2012-09-21 18:59:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1158223 | Affymax Inc | AFFY | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1419580 | Robert Venteicher | C/O Affymax, Inc. 4001 Miranda Ave. Palo Alto CA 94304 | Svp, Technical Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-09-19 | 10,000 | $5.83 | 34,994 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-09-19 | 4,062 | $7.99 | 39,056 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-09-19 | 10,000 | $20.82 | 29,056 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-09-19 | 4,062 | $21.00 | 24,994 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-09-21 | 1,075 | $10.99 | 26,069 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-09-21 | 3,125 | $15.00 | 29,194 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-09-21 | 4,200 | $22.00 | 24,994 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock (Right to Buy) | Disposition | 2012-09-19 | 10,000 | $0.00 | 10,000 | $5.83 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-09-19 | 4,062 | $0.00 | 4,062 | $7.99 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-09-21 | 1,075 | $0.00 | 1,075 | $10.99 |
| Common Stock | Stock Option (Right To Buy) | Disposition | 2012-09-21 | 3,125 | $0.00 | 3,125 | $15.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 30,000 | 2020-09-21 | No | 4 | M | Direct | |
| 20,313 | 2022-01-30 | No | 4 | M | Direct | |
| 31,925 | 2019-01-14 | No | 4 | M | Direct | |
| 0 | 2018-05-28 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.45 to $20.915,inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- The shares vest and become exercisable in a series of forty-eight (48) successive equal monthly installments over the four (4) year period measured from September 22, 2010.
- The shares vest and become exercisable in a series of forty-eight (48) successive equal monthly installments over the four (4) year period beginning January 1, 2012.
- The shares vest and become exercisable in a series of forty-eight (48) successive equal monthly installments over the four (4) year period measured from January 1, 2009.
- The option becomes exercisable in equal monthly installments over four years from June 1, 2008.
Billionaire Hedge Funds
